Lupus Trials News
January 16, 2020 With so few current treatment options for lupus and lupus nephritis, patients may benefit from joining a...Read More
January 16, 2020 Up to half of people with lupus will have lupus nephritis – damage to the kidneys that...Read More
January 7, 2020 2019 was a phenomenal, breakthrough year for lupus research on both the clinical development and basic science...Read More
January 6, 2020 New research published in Arthritis and Rheumatology shows that peripheral nervous system (PNS) disease is an important...Read More
December 18, 2019 The Lupus Research Alliance (LRA) welcomes additional positive results published today in the New England Journal of...Read More
December 17, 2019 The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive...Read More
December 10, 2019 The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by...Read More
December 4, 2019 The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase III trial results for...Read More
December 3, 2019 The Lupus Research Alliance (LRA) is pleased to share positive results reported by Biogen Inc. from the...Read More
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019 The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...Read More
November 12, 2019 Two positive clinical studies presented at the 2019 ACR/ARP Annual Meeting were conducted through the Lupus Clinical...Read More
November 8, 2019 Aurinia Pharmaceuticals announced results from a study showing that their investigational drug voclosporin did not significantly impact...Read More
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
NEW YORK, NY – November 11. The Lupus Research Alliance (LRA) congratulates AstraZeneca on new positive results from the Phase...Read More
Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
NEW YORK, Nov. 10, 2019 /PRNewswire/ — The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented by Genentech...Read More
Includes 16 presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from two...Read More
October 28, 2019 Because lupus is hard to diagnose, many patients don’t get the treatments they need, while others get...Read More
October 17, 2019 A new study published in the European Journal of Neurology showed that epilepsy is significantly more common...Read More
October 7, 2019 A new study published in Annals of the Rheumatic Diseases found that among people with lupus, high...Read More
October 1, 2019 The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...Read More
September 26, 2019 In a newly published Michigan study, nearly 1 in 3 adults with systemic lupus erythematosus used prescription...Read More
June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in...
March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...
February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...
A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....
An observational study published in Lupus of people with lupus found that of six factors, stress, depression and pain contributed most to...
A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...
Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA) announced that the first patient has been enrolled into a multiple-dose study...
A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...